Drug intelligence / Profile preview

ACE Pico Retino

Development stage: Unknown
Lead developer: Ace Cells Lab
Modality: Small Molecules
Administration: Oral

Overview

ACE Pico Retino is an oral liquid dietary supplement developed by Ace Cells Lab, a UK-based company. It is formulated with a synergistic blend of amino acids, antioxidants, and carotenoids designed to support retinal health, visual performance, and the maintenance of normal vision. Marketed as part of a wellness product line purportedly powered by stem cell technology, ACE Pico Retino functions as a nutritional supplement providing essential nutrients for eye clarity and function rather than an investigational pharmaceutical drug with a specific molecular target.

Brand names: ACE Pico Retino

Beyond the preview

Go deeper on ACE Pico Retino.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACE Pico Retino.

Explore the full profile